Effect of perfusion temperature and chemotherapy on tumor cell death after HIPEC for treatment of patients with peritoneal carcinomatosis

Martin Gasser, Malte Vetterlein, Eva Moll, Tanja Grimmig, Maria Lazariotou, Christoph-Thomas Germer, Ana Maria Waaga-Gasser & Jörg Pelz
Introduction: In patients with peritoneal carcinomatosis (PC) from gastrointestinal cancer hyperthermic intraperitoneal chemoperfusion (HIPEC) represents a treatment option integrated into multimodal concepts. In order to optimize current HIPEC conditions we analyzed different perfusion temperatures[for full text, please go to the a.m. URL]